Biochem/physiol Actions
Primary TargetPI-PLC
Reversible: yes
Target IC50: 9.6 µM against phosphatidylinositol-specific phospholipase C (PI-PLC)
Product does not compete with ATP.
Cell permeable: yes
Caution
Material may form micelles in aqueous stock solutions, which may affect experimental results.
General description
A cell-permeable and reversible cytotoxic agent that shows selective cytocidal activity against neoplastic cells and virally transformed cells. Selectively inhibits phosphatidylinositol-specific phospholipase C (PI-PLC, IC50 = 9.6 µM) but does not inhibit phosphatidylcholine-specific PLC or PLD. Inhibits protein kinase C from various leukemic cells. Also promotes rapid and selective apoptosis in human leukemic cells. Has strong antitumor and anticancer properties.
A cell-permeable and reversible cytotoxic agent that shows selective cytocidal activity against neoplastic cells and virally transformed cells. Selectively inhibits phosphatidylinositol-specific phospholipase C (PI-PLC, IC50 = 9.6 µM) but does not inhibit phosphatidylcholine-specific PLC or PLD. Promotes apoptosis in mitogen-activated, but not resting, T lymphocytes in a dose- and time-dependent manner. Also promotes rapid and selective apoptosis in human leukemic cells.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Harguindey, J., et al. 2000. Apoptosis5, 87.Cabaner, C., et al. 1999. Br. J. Pharmacol. 127, 813.Powis, G., and Phil, D. 1994. Cancer Metastasis Rev.13, 91.Helfman, D., et al. 1993. Cancer Res. 53, 2955.Mollinedo, F., et al. 1993. Biochem. Biophys. Res. Commun. 192, 603.Powis, G., et al. 1992. Cancer Res.52, 2835.Oishi, K., et al. 1988. Biochem. Biophys. Res. Commun.157, 1000.
Packaging
5 mg in Plastic ampoule
Reconstitution
Following reconstitution in ethanol, aliquot and freeze (-20°C). Ethanol stock solutions are stable for up to 3 months at -20°C. Unstable in aqueous solution; reconstitute just prior to use.
Warning
Toxicity: Carcinogenic / Teratogenic (D)
This product has met the following criteria to qualify for the following awards: